Oxford Nanopore Technologies

Timeline

Health & Bio Today: EMV Capital spotlights XF-73 ahead of Phase 3, IXICO, Oxford Nanopore, AstraZeneca

23:13, 21 May 2026

Oxford Nanopore appoints first CMO and new CIO

14:22, 21 May 2026

More in Telecoms

Telecoms

Vodafone Group shares soar after stake sale to Xavier Niel

French billionaire Xavier Niel is investing in Vodafone Group via his Vega entity, with funding provided entirely by Niel personally and financial institutions.

Updated 12:43, 10 Jul 2026

Cybersecurity

BATM secures three-year contract extension with major US broadband operator

07:43, 6 Jul 2026

AI & Machine Learning

Tech Today: Craneware warns FY26 revenue and profit to miss expectations, MedPal AI, Crimson Tide, Quantum Blockchain Technologies, Defence Holdings

17:04, 3 Jul 2026

Medtech & Diagnostics

MedPal AI raises £5m to acquire care-home software firm and launch oral Wegovy clinic

07:53, 3 Jul 2026

Hardware & Electronics

Tech Today: Shearwater lands £25m contract extension, Iconic Labs, MedPal AI, Amcomri

17:03, 1 Jul 2026

Cybersecurity

Shearwater Group shares up sharply on £25m contract extension

Updated 12:19, 1 Jul 2026

Healthcare Services

MedPal AI opens largest robotic dispensing facility in Runcorn with NHS approval

10:06, 1 Jul 2026

Software & SaaS

Tech Today: Made Tech beats upgraded guidance, Chill Brands, CloudCoCo, PipeHawk, GenIP, Smarter Web Company

17:04, 30 Jun 2026

Retail

Chill Brands revenue grows, but financials show investment outpaced income

12:47, 30 Jun 2026

Biotech

Oxford BioDynamics shows revenue growth, new CEO starts, and lands a new US partnership

09:27, 30 Jun 2026

Telecoms

Tech Today: BT and Verizon merge international units in $4bn JV, Cloudified, Arcontech, Trustpilot

17:33, 29 Jun 2026

Oxford Nanopore Technologies develops and commercializes nanopore sequencing technology for DNA and RNA analysis, serving research, clinical diagnostics, and infectious disease monitoring markets. The company operates globally with significant presence in Europe and North America, competing in the genomic sequencing instrumentation and consumables sector. As a mid-cap public company listed on the London Stock Exchange, Oxford Nanopore is in a growth phase with recurring revenue from instrument sales and consumables, though currently unprofitable on an operating basis.

Sector: Telecoms
Market: MAINMARKET

Identifiers

Ticker: LSE:ONT
Market: MAINMARKET
ISIN: GB00BP6S8Z30
LEI: 213800IRWQ2Q6M2CDW55

Learn more on:

GLEIF Companies House

Timeline

Health & Bio Today: EMV Capital spotlights XF-73 ahead of Phase 3, IXICO, Oxford Nanopore, AstraZeneca

Oxford Nanopore appoints first CMO and new CIO

More in Telecoms

Vodafone Group shares soar after stake sale to Xavier Niel

BATM secures three-year contract extension with major US broadband operator

Tech Today: Craneware warns FY26 revenue and profit to miss expectations, MedPal AI, Crimson Tide, Quantum Blockchain Technologies, Defence Holdings

MedPal AI raises £5m to acquire care-home software firm and launch oral Wegovy clinic

Tech Today: Shearwater lands £25m contract extension, Iconic Labs, MedPal AI, Amcomri

Shearwater Group shares up sharply on £25m contract extension

MedPal AI opens largest robotic dispensing facility in Runcorn with NHS approval

Tech Today: Made Tech beats upgraded guidance, Chill Brands, CloudCoCo, PipeHawk, GenIP, Smarter Web Company

Chill Brands revenue grows, but financials show investment outpaced income

Oxford BioDynamics shows revenue growth, new CEO starts, and lands a new US partnership

Tech Today: BT and Verizon merge international units in $4bn JV, Cloudified, Arcontech, Trustpilot

Browse by Sector

Market reports

Energy & Resources

Financials

Technology

Healthcare

Industrials

Consumer